Zr-89 Cimzia PET Imaging Rheumatoid Arthritis

Summary

This is a single center exploratory imaging study investigating the initial application of zirconium-89 Deferoxamine B Certolizumab pegol (89Zr-DFO-CZP) PET in patients with rheumatoid arthritis. Patients with active symptoms of RA or signs on physical exam will be invited to participate for PET imaging.

Timeline

Start

2018-10-01

Primary completion

2029-03-31

Completion

2029-03-31

Outcome

Outcome not reported

Stopped (Business): “Lapse in study funding.”

Drugs

Indications